Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
We use our state-of-the-art dedicated workflow for designing focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
Utilising molecular simulations, our approach thoroughly examines a wide array of proteins, tracking their conformational changes individually and within complexes. Ensemble virtual screening enables us to address conformational flexibility, revealing essential binding sites at functional regions and allosteric locations. Our rigorous analysis guarantees that no potential mechanism of action is overlooked, aiming to uncover new therapeutic targets and lead compounds across diverse biological functions.
Several key aspects differentiate our library:
partner
Reaxense
upacc
P17987
UPID:
TCPA_HUMAN
Alternative names:
CCT-alpha
Alternative UPACC:
P17987; E1P5B2; Q15556; Q5TCM3
Background:
T-complex protein 1 subunit alpha (CCT-alpha) is a crucial component of the chaperonin-containing T-complex (TRiC), a molecular chaperone complex vital for protein folding upon ATP hydrolysis. It plays a significant role in telomere maintenance by mediating the folding of WRAP53/TCAB1, and is involved in ciliogenesis by assisting in the assembly of the BBSome complex. Additionally, the TRiC complex is essential for the proper folding of actin and tubulin.
Therapeutic significance:
Understanding the role of T-complex protein 1 subunit alpha could open doors to potential therapeutic strategies.